​

Cencora (COR) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

COR Stock Forecast

Cencora (COR) stock forecast, based on 46 Wall Street analysts, predicts a 12-month average price target of $410.50, with a high of $440.00 and a low of $340.00. This represents a 16.40% increase from the last price of $352.65.

$200 $250 $300 $350 $400 $450 High: $440 Avg: $410.5 Low: $340 Last Closed Price: $352.65

COR Stock Rating

Cencora stock's rating consensus is Buy, based on 46 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 33 Buy (71.74%), 12 Hold (26.09%), 1 Sell (2.17%), and 0 Strong Sell (0.00%).

Buy
Total 46 1 12 33 Strong Sell Sell Hold Buy Strong Buy

COR Price Target Upside V Benchmarks

TypeNameUpside
StockCencora16.40%
SectorHealthcare Stocks 15.45%
IndustryMedical Distribution Stocks12.44%

Price Target Trends

1M3M12M
# Anlaysts-717
Avg Price Target-$417.29$382.47
Last Closing Price$352.65$352.65$352.65
Upside/Downside-18.33%8.46%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Mar, 263103--16
Feb, 263112-117
Jan, 262104-117
Dec, 251104-116
Nov, 251104-116
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Feb 13, 2026Barclays$425.00$351.0621.06%20.52%
Feb 10, 2026Wells Fargo$429.00$363.2718.09%21.65%
Feb 05, 2026Evercore ISI$420.00$354.8318.37%19.10%
Jan 29, 2026Morgan Stanley$400.00$350.5414.11%13.43%
Jan 22, 2026Brian TanquilutJefferies$440.00$351.7525.09%24.77%
Jan 13, 2026Eric ColdwellRobert W. Baird$415.00$345.3020.19%17.68%
Dec 16, 2025Robert W. Baird$392.00$345.6413.41%11.16%
Dec 08, 2025Barclays$400.00$337.8218.41%13.43%
Nov 07, 2025Kevin CaliendoUBS$415.00$363.5814.14%17.68%
Nov 06, 2025Evercore ISI$400.00$352.1313.59%13.43%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Feb 13, 2026BarclaysOverweightOverweighthold
Feb 10, 2026Wells FargoOverweightOverweighthold
Jan 29, 2026Morgan StanleyOverweightOverweightupgrade
Jan 22, 2026JefferiesUnderperformBuyupgrade
Jan 05, 2026Bank of America SecuritiesNeutralNeutralhold
Dec 08, 2025BarclaysUnderweightOverweightinitialise
Nov 06, 2025Evercore ISIOutperformOutperformhold
Oct 27, 2025UBSBuyBuyhold
Aug 13, 2025Wells FargoOverweightOverweighthold
Jun 03, 2025Wells FargoEqual-WeightOverweightupgrade

Financial Forecast

EPS Forecast

$0 $5 $10 $15 $20 $25 Sep 21 Sep 22 Sep 23 Sep 24 Sep 25 Sep 26 Sep 27 Sep 28 Sep 29
Sep 21Sep 22Sep 23Sep 24Sep 25Sep 26Sep 27Sep 28Sep 29
Reported$7.48$8.15$8.62$7.60$8.03----
Avg Forecast$9.23$2.78$11.93$13.65$15.16$16.59$18.15$20.68$22.96
High Forecast$9.47$3.33$11.95$13.67$15.46$17.17$20.01$21.30$23.65
Low Forecast$8.79$2.23$11.90$13.60$14.89$16.13$16.40$20.26$22.49
Surprise %-18.96%193.17%-27.75%-44.32%-47.03%----

Revenue Forecast

$0 $100B $200B $300B $400B $500B Sep 21 Sep 22 Sep 23 Sep 24 Sep 25 Sep 26 Sep 27 Sep 28 Sep 29
Sep 21Sep 22Sep 23Sep 24Sep 25Sep 26Sep 27Sep 28Sep 29
Reported$213.99B$238.59B$262.17B$293.96B$321.33B----
Avg Forecast$212.20B$708.52M$259.67B$292.54B$320.22B$340.96B$363.69B$404.37B$443.83B
High Forecast$216.34B$850.22M$261.65B$293.25B$324.52B$348.77B$364.51B$413.74B$454.12B
Low Forecast$204.32B$566.81M$257.87B$291.78B$316.92B$334.75B$362.87B$398.07B$436.91B
Surprise %0.84%33574.22%0.96%0.49%0.35%----

Net Income Forecast

$0 $1B $2B $3B $4B $5B Sep 21 Sep 22 Sep 23 Sep 24 Sep 25 Sep 26 Sep 27 Sep 28 Sep 29
Sep 21Sep 22Sep 23Sep 24Sep 25Sep 26Sep 27Sep 28Sep 29
Reported$1.54B$1.70B$1.75B$1.51B$1.55B----
Avg Forecast$82.85M$91.14M$1.87B$2.73B$3.04B$3.33B$3.65B$4.14B$4.60B
High Forecast$99.43M$109.37M$2.24B$2.74B$3.10B$3.44B$4.01B$4.27B$4.74B
Low Forecast$66.28M$72.91M$1.49B$2.72B$2.98B$3.23B$3.28B$4.06B$4.51B
Surprise %1758.59%1763.96%-6.52%-44.74%-48.86%----

COR Forecast FAQ

Is Cencora stock a buy?

Cencora stock has a consensus rating of Buy, based on 46 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 33 Buy, 12 Hold, 1 Sell, and 0 Strong Sell, reflecting a consensus that Cencora is a favorable investment for most analysts.

What is Cencora's price target?

Cencora's price target, set by 46 Wall Street analysts, averages $410.5 over the next 12 months. The price target range spans from $340 at the low end to $440 at the high end, suggesting a potential 16.40% change from the previous closing price of $352.65.

How does Cencora stock forecast compare to its benchmarks?

Cencora's stock forecast shows a 16.40% upside, outperforming the average forecast for the healthcare stocks sector (15.45%) and outperforming the medical distribution stocks industry (12.44%).

What is the breakdown of analyst ratings for Cencora over the past three months?

  • March 2026: 18.75% Strong Buy, 62.50% Buy, 18.75% Hold, 0% Sell, 0% Strong Sell.
  • February 2026: 17.65% Strong Buy, 64.71% Buy, 11.76% Hold, 0% Sell, 5.88% Strong Sell.
  • January 2026: 11.76% Strong Buy, 58.82% Buy, 23.53% Hold, 0% Sell, 5.88% Strong Sell.

What is Cencora’s EPS forecast?

Cencora's average annual EPS forecast for its fiscal year ending in September 2026 is $16.59, marking a 106.60% increase from the reported $8.03 in 2025. Estimates for the following years are $18.15 in 2027, $20.68 in 2028, and $22.96 in 2029.

What is Cencora’s revenue forecast?

Cencora's average annual revenue forecast for its fiscal year ending in September 2026 is $340.96B, reflecting a 6.11% increase from the reported $321.33B in 2025. The forecast for 2027 is $363.69B, followed by $404.37B for 2028, and $443.83B for 2029.

What is Cencora’s net income forecast?

Cencora's net income forecast for the fiscal year ending in September 2026 stands at $3.33B, representing an 114.57% increase from the reported $1.55B in 2025. Projections indicate $3.65B in 2027, $4.14B in 2028, and $4.6B in 2029.